Publication | Open Access
Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide
68
Citations
33
References
2018
Year
5-Aza provided a survival benefit as a single agent but worked best in combination with TMZ in 2 different IDH1 R132H mutant glioma models.
| Year | Citations | |
|---|---|---|
Page 1
Page 1